ID
45858
Beschrijving
Principal Investigator: Levi A. Garraway, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001018 We performed comprehensive molecular profiling of renal tumors, including whole exome sequencing and transcriptome sequencing, derived from patient samples. This project additionally explores mechanisms of response and resistance to existing and emerging therapies in this disease, as well as mechanisms of tumor evolution in the context of treatment.
Link
Trefwoorden
Versies (1)
- 08-10-23 08-10-23 - Simon Heim
Houder van rechten
Levi A. Garraway, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA
Geüploaded op
8 oktober 2023
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs001018 Molecular Characterization of Clinical Renal Tumors
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and sample ID of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and affection status of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Sample ID, analyte type, tumor status of sample, and cell or tissue type or subtype of sample obtained from participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and sample ID of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Subject ID and affection status of participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
- Sample ID, analyte type, tumor status of sample, and cell or tissue type or subtype of sample obtained from participants with renal tumors and involved in the "Molecular Characterization of Clinical Renal Tumors" project.
C0680251 (UMLS CUI [1,2])
C0740457 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
C0475358 (UMLS CUI [1,4])
C3845275 (UMLS CUI [1,5])